Nanopublications LDF server

Matches in Nanopublications for { ?s ?p "(75 9% vs 40 0%, P-value=0 012) Further, early dexamethasone group showed a significantly shorter, total duration of oxygen supplementation, (10, 45 d, vs, 21, 61, d,, P-value=0, 003) and length of stay in the hospital (19 76 d, vs 27, 21, d,, P-value=0, 013), However,, extracorporeal membrane, oxygenation and in-hospital mortality rates were not significantly different between groups that received dexamethasone either within 24 hours of hypoxemia (early, dexamethasone, group) or 24 hours." ?g. }

• SENTENCE label "(75 9% vs 40 0%, P-value=0 012) Further, early dexamethasone group showed a significantly shorter, total duration of oxygen supplementation, (10, 45 d, vs, 21, 61, d,, P-value=0, 003) and length of stay in the hospital (19 76 d, vs 27, 21, d,, P-value=0, 013), However,, extracorporeal membrane, oxygenation and in-hospital mortality rates were not significantly different between groups that received dexamethasone either within 24 hours of hypoxemia (early, dexamethasone, group) or 24 hours." provenance.
• SENTENCE label "(75 9% vs 40 0%, P-value=0 012) Further, early dexamethasone group showed a significantly shorter, total duration of oxygen supplementation, (10, 45 d, vs, 21, 61, d,, P-value=0, 003) and length of stay in the hospital (19 76 d, vs 27, 21, d,, P-value=0, 013), However,, extracorporeal membrane, oxygenation and in-hospital mortality rates were not significantly different between groups that received dexamethasone either within 24 hours of hypoxemia (early, dexamethasone, group) or 24 hours." provenance.
• SENTENCE label "(75 9% vs 40 0%, P-value=0 012) Further, early dexamethasone group showed a significantly shorter, total duration of oxygen supplementation, (10, 45 d, vs, 21, 61, d,, P-value=0, 003) and length of stay in the hospital (19 76 d, vs 27, 21, d,, P-value=0, 013), However,, extracorporeal membrane, oxygenation and in-hospital mortality rates were not significantly different between groups that received dexamethasone either within 24 hours of hypoxemia (early, dexamethasone, group) or 24 hours." provenance.
• SENTENCE label "(75 9% vs 40 0%, P-value=0 012) Further, early dexamethasone group showed a significantly shorter, total duration of oxygen supplementation, (10, 45 d, vs, 21, 61, d,, P-value=0, 003) and length of stay in the hospital (19 76 d, vs 27, 21, d,, P-value=0, 013), However,, extracorporeal membrane, oxygenation and in-hospital mortality rates were not significantly different between groups that received dexamethasone either within 24 hours of hypoxemia (early, dexamethasone, group) or 24 hours." provenance.
• SENTENCE label "(75 9% vs 40 0%, P-value=0 012) Further, early dexamethasone group showed a significantly shorter, total duration of oxygen supplementation, (10, 45 d, vs, 21, 61, d,, P-value=0, 003) and length of stay in the hospital (19 76 d, vs 27, 21, d,, P-value=0, 013), However,, extracorporeal membrane, oxygenation and in-hospital mortality rates were not significantly different between groups that received dexamethasone either within 24 hours of hypoxemia (early, dexamethasone, group) or 24 hours." provenance.
• SENTENCE label "(75 9% vs 40 0%, P-value=0 012) Further, early dexamethasone group showed a significantly shorter, total duration of oxygen supplementation, (10, 45 d, vs, 21, 61, d,, P-value=0, 003) and length of stay in the hospital (19 76 d, vs 27, 21, d,, P-value=0, 013), However,, extracorporeal membrane, oxygenation and in-hospital mortality rates were not significantly different between groups that received dexamethasone either within 24 hours of hypoxemia (early, dexamethasone, group) or 24 hours." provenance.
• SENTENCE label "(75 9% vs 40 0%, P-value=0 012) Further, early dexamethasone group showed a significantly shorter, total duration of oxygen supplementation, (10, 45 d, vs, 21, 61, d,, P-value=0, 003) and length of stay in the hospital (19 76 d, vs 27, 21, d,, P-value=0, 013), However,, extracorporeal membrane, oxygenation and in-hospital mortality rates were not significantly different between groups that received dexamethasone either within 24 hours of hypoxemia (early, dexamethasone, group) or 24 hours." provenance.
• SENTENCE label "(75 9% vs 40 0%, P-value=0 012) Further, early dexamethasone group showed a significantly shorter, total duration of oxygen supplementation, (10, 45 d, vs, 21, 61, d,, P-value=0, 003) and length of stay in the hospital (19 76 d, vs 27, 21, d,, P-value=0, 013), However,, extracorporeal membrane, oxygenation and in-hospital mortality rates were not significantly different between groups that received dexamethasone either within 24 hours of hypoxemia (early, dexamethasone, group) or 24 hours." provenance.
• SENTENCE label "(75 9% vs 40 0%, P-value=0 012) Further, early dexamethasone group showed a significantly shorter, total duration of oxygen supplementation, (10, 45 d, vs, 21, 61, d,, P-value=0, 003) and length of stay in the hospital (19 76 d, vs 27, 21, d,, P-value=0, 013), However,, extracorporeal membrane, oxygenation and in-hospital mortality rates were not significantly different between groups that received dexamethasone either within 24 hours of hypoxemia (early, dexamethasone, group) or 24 hours." provenance.
• SENTENCE label "(75 9% vs 40 0%, P-value=0 012) Further, early dexamethasone group showed a significantly shorter, total duration of oxygen supplementation, (10, 45 d, vs, 21, 61, d,, P-value=0, 003) and length of stay in the hospital (19 76 d, vs 27, 21, d,, P-value=0, 013), However,, extracorporeal membrane, oxygenation and in-hospital mortality rates were not significantly different between groups that received dexamethasone either within 24 hours of hypoxemia (early, dexamethasone, group) or 24 hours." provenance.
• SENTENCE label "(75 9% vs 40 0%, P-value=0 012) Further, early dexamethasone group showed a significantly shorter, total duration of oxygen supplementation, (10, 45 d, vs, 21, 61, d,, P-value=0, 003) and length of stay in the hospital (19 76 d, vs 27, 21, d,, P-value=0, 013), However,, extracorporeal membrane, oxygenation and in-hospital mortality rates were not significantly different between groups that received dexamethasone either within 24 hours of hypoxemia (early, dexamethasone, group) or 24 hours." provenance.
• SENTENCE label "(75 9% vs 40 0%, P-value=0 012) Further, early dexamethasone group showed a significantly shorter, total duration of oxygen supplementation, (10, 45 d, vs, 21, 61, d,, P-value=0, 003) and length of stay in the hospital (19 76 d, vs 27, 21, d,, P-value=0, 013), However,, extracorporeal membrane, oxygenation and in-hospital mortality rates were not significantly different between groups that received dexamethasone either within 24 hours of hypoxemia (early, dexamethasone, group) or 24 hours." provenance.
• SENTENCE label "(75 9% vs 40 0%, P-value=0 012) Further, early dexamethasone group showed a significantly shorter, total duration of oxygen supplementation, (10, 45 d, vs, 21, 61, d,, P-value=0, 003) and length of stay in the hospital (19 76 d, vs 27, 21, d,, P-value=0, 013), However,, extracorporeal membrane, oxygenation and in-hospital mortality rates were not significantly different between groups that received dexamethasone either within 24 hours of hypoxemia (early, dexamethasone, group) or 24 hours." provenance.
• SENTENCE label "(75 9% vs 40 0%, P-value=0 012) Further, early dexamethasone group showed a significantly shorter, total duration of oxygen supplementation, (10, 45 d, vs, 21, 61, d,, P-value=0, 003) and length of stay in the hospital (19 76 d, vs 27, 21, d,, P-value=0, 013), However,, extracorporeal membrane, oxygenation and in-hospital mortality rates were not significantly different between groups that received dexamethasone either within 24 hours of hypoxemia (early, dexamethasone, group) or 24 hours." provenance.
• SENTENCE label "(75 9% vs 40 0%, P-value=0 012) Further, early dexamethasone group showed a significantly shorter, total duration of oxygen supplementation, (10, 45 d, vs, 21, 61, d,, P-value=0, 003) and length of stay in the hospital (19 76 d, vs 27, 21, d,, P-value=0, 013), However,, extracorporeal membrane, oxygenation and in-hospital mortality rates were not significantly different between groups that received dexamethasone either within 24 hours of hypoxemia (early, dexamethasone, group) or 24 hours." provenance.
• SENTENCE label "(75 9% vs 40 0%, P-value=0 012) Further, early dexamethasone group showed a significantly shorter, total duration of oxygen supplementation, (10, 45 d, vs, 21, 61, d,, P-value=0, 003) and length of stay in the hospital (19 76 d, vs 27, 21, d,, P-value=0, 013), However,, extracorporeal membrane, oxygenation and in-hospital mortality rates were not significantly different between groups that received dexamethasone either within 24 hours of hypoxemia (early, dexamethasone, group) or 24 hours." provenance.
• SENTENCE label "(75 9% vs 40 0%, P-value=0 012) Further, early dexamethasone group showed a significantly shorter, total duration of oxygen supplementation, (10, 45 d, vs, 21, 61, d,, P-value=0, 003) and length of stay in the hospital (19 76 d, vs 27, 21, d,, P-value=0, 013), However,, extracorporeal membrane, oxygenation and in-hospital mortality rates were not significantly different between groups that received dexamethasone either within 24 hours of hypoxemia (early, dexamethasone, group) or 24 hours." provenance.
• SENTENCE label "(75 9% vs 40 0%, P-value=0 012) Further, early dexamethasone group showed a significantly shorter, total duration of oxygen supplementation, (10, 45 d, vs, 21, 61, d,, P-value=0, 003) and length of stay in the hospital (19 76 d, vs 27, 21, d,, P-value=0, 013), However,, extracorporeal membrane, oxygenation and in-hospital mortality rates were not significantly different between groups that received dexamethasone either within 24 hours of hypoxemia (early, dexamethasone, group) or 24 hours." provenance.
• SENTENCE label "(75 9% vs 40 0%, P-value=0 012) Further, early dexamethasone group showed a significantly shorter, total duration of oxygen supplementation, (10, 45 d, vs, 21, 61, d,, P-value=0, 003) and length of stay in the hospital (19 76 d, vs 27, 21, d,, P-value=0, 013), However,, extracorporeal membrane, oxygenation and in-hospital mortality rates were not significantly different between groups that received dexamethasone either within 24 hours of hypoxemia (early, dexamethasone, group) or 24 hours." provenance.
• SENTENCE label "(75 9% vs 40 0%, P-value=0 012) Further, early dexamethasone group showed a significantly shorter, total duration of oxygen supplementation, (10, 45 d, vs, 21, 61, d,, P-value=0, 003) and length of stay in the hospital (19 76 d, vs 27, 21, d,, P-value=0, 013), However,, extracorporeal membrane, oxygenation and in-hospital mortality rates were not significantly different between groups that received dexamethasone either within 24 hours of hypoxemia (early, dexamethasone, group) or 24 hours." provenance.
• SENTENCE label "(75 9% vs 40 0%, P-value=0 012) Further, early dexamethasone group showed a significantly shorter, total duration of oxygen supplementation, (10, 45 d, vs, 21, 61, d,, P-value=0, 003) and length of stay in the hospital (19 76 d, vs 27, 21, d,, P-value=0, 013), However,, extracorporeal membrane, oxygenation and in-hospital mortality rates were not significantly different between groups that received dexamethasone either within 24 hours of hypoxemia (early, dexamethasone, group) or 24 hours." provenance.
• SENTENCE label "(75 9% vs 40 0%, P-value=0 012) Further, early dexamethasone group showed a significantly shorter, total duration of oxygen supplementation, (10, 45 d, vs, 21, 61, d,, P-value=0, 003) and length of stay in the hospital (19 76 d, vs 27, 21, d,, P-value=0, 013), However,, extracorporeal membrane, oxygenation and in-hospital mortality rates were not significantly different between groups that received dexamethasone either within 24 hours of hypoxemia (early, dexamethasone, group) or 24 hours." provenance.
• SENTENCE label "(75 9% vs 40 0%, P-value=0 012) Further, early dexamethasone group showed a significantly shorter, total duration of oxygen supplementation, (10, 45 d, vs, 21, 61, d,, P-value=0, 003) and length of stay in the hospital (19 76 d, vs 27, 21, d,, P-value=0, 013), However,, extracorporeal membrane, oxygenation and in-hospital mortality rates were not significantly different between groups that received dexamethasone either within 24 hours of hypoxemia (early, dexamethasone, group) or 24 hours." provenance.
• SENTENCE label "(75 9% vs 40 0%, P-value=0 012) Further, early dexamethasone group showed a significantly shorter, total duration of oxygen supplementation, (10, 45 d, vs, 21, 61, d,, P-value=0, 003) and length of stay in the hospital (19 76 d, vs 27, 21, d,, P-value=0, 013), However,, extracorporeal membrane, oxygenation and in-hospital mortality rates were not significantly different between groups that received dexamethasone either within 24 hours of hypoxemia (early, dexamethasone, group) or 24 hours." provenance.
• SENTENCE label "(75 9% vs 40 0%, P-value=0 012) Further, early dexamethasone group showed a significantly shorter, total duration of oxygen supplementation, (10, 45 d, vs, 21, 61, d,, P-value=0, 003) and length of stay in the hospital (19 76 d, vs 27, 21, d,, P-value=0, 013), However,, extracorporeal membrane, oxygenation and in-hospital mortality rates were not significantly different between groups that received dexamethasone either within 24 hours of hypoxemia (early, dexamethasone, group) or 24 hours." provenance.
• SENTENCE label "(75 9% vs 40 0%, P-value=0 012) Further, early dexamethasone group showed a significantly shorter, total duration of oxygen supplementation, (10, 45 d, vs, 21, 61, d,, P-value=0, 003) and length of stay in the hospital (19 76 d, vs 27, 21, d,, P-value=0, 013), However,, extracorporeal membrane, oxygenation and in-hospital mortality rates were not significantly different between groups that received dexamethasone either within 24 hours of hypoxemia (early, dexamethasone, group) or 24 hours." provenance.
• SENTENCE label "(75 9% vs 40 0%, P-value=0 012) Further, early dexamethasone group showed a significantly shorter, total duration of oxygen supplementation, (10, 45 d, vs, 21, 61, d,, P-value=0, 003) and length of stay in the hospital (19 76 d, vs 27, 21, d,, P-value=0, 013), However,, extracorporeal membrane, oxygenation and in-hospital mortality rates were not significantly different between groups that received dexamethasone either within 24 hours of hypoxemia (early, dexamethasone, group) or 24 hours." provenance.
• SENTENCE label "(75 9% vs 40 0%, P-value=0 012) Further, early dexamethasone group showed a significantly shorter, total duration of oxygen supplementation, (10, 45 d, vs, 21, 61, d,, P-value=0, 003) and length of stay in the hospital (19 76 d, vs 27, 21, d,, P-value=0, 013), However,, extracorporeal membrane, oxygenation and in-hospital mortality rates were not significantly different between groups that received dexamethasone either within 24 hours of hypoxemia (early, dexamethasone, group) or 24 hours." provenance.
• SENTENCE label "(75 9% vs 40 0%, P-value=0 012) Further, early dexamethasone group showed a significantly shorter, total duration of oxygen supplementation, (10, 45 d, vs, 21, 61, d,, P-value=0, 003) and length of stay in the hospital (19 76 d, vs 27, 21, d,, P-value=0, 013), However,, extracorporeal membrane, oxygenation and in-hospital mortality rates were not significantly different between groups that received dexamethasone either within 24 hours of hypoxemia (early, dexamethasone, group) or 24 hours." provenance.
• SENTENCE label "(75 9% vs 40 0%, P-value=0 012) Further, early dexamethasone group showed a significantly shorter, total duration of oxygen supplementation, (10, 45 d, vs, 21, 61, d,, P-value=0, 003) and length of stay in the hospital (19 76 d, vs 27, 21, d,, P-value=0, 013), However,, extracorporeal membrane, oxygenation and in-hospital mortality rates were not significantly different between groups that received dexamethasone either within 24 hours of hypoxemia (early, dexamethasone, group) or 24 hours." provenance.
• SENTENCE label "(75 9% vs 40 0%, P-value=0 012) Further, early dexamethasone group showed a significantly shorter, total duration of oxygen supplementation, (10, 45 d, vs, 21, 61, d,, P-value=0, 003) and length of stay in the hospital (19 76 d, vs 27, 21, d,, P-value=0, 013), However,, extracorporeal membrane, oxygenation and in-hospital mortality rates were not significantly different between groups that received dexamethasone either within 24 hours of hypoxemia (early, dexamethasone, group) or 24 hours." provenance.
• SENTENCE label "(75 9% vs 40 0%, P-value=0 012) Further, early dexamethasone group showed a significantly shorter, total duration of oxygen supplementation, (10, 45 d, vs, 21, 61, d,, P-value=0, 003) and length of stay in the hospital (19 76 d, vs 27, 21, d,, P-value=0, 013), However,, extracorporeal membrane, oxygenation and in-hospital mortality rates were not significantly different between groups that received dexamethasone either within 24 hours of hypoxemia (early, dexamethasone, group) or 24 hours." provenance.
• SENTENCE label "(75 9% vs 40 0%, P-value=0 012) Further, early dexamethasone group showed a significantly shorter, total duration of oxygen supplementation, (10, 45 d, vs, 21, 61, d,, P-value=0, 003) and length of stay in the hospital (19 76 d, vs 27, 21, d,, P-value=0, 013), However,, extracorporeal membrane, oxygenation and in-hospital mortality rates were not significantly different between groups that received dexamethasone either within 24 hours of hypoxemia (early, dexamethasone, group) or 24 hours." provenance.
• SENTENCE label "(75 9% vs 40 0%, P-value=0 012) Further, early dexamethasone group showed a significantly shorter, total duration of oxygen supplementation, (10, 45 d, vs, 21, 61, d,, P-value=0, 003) and length of stay in the hospital (19 76 d, vs 27, 21, d,, P-value=0, 013), However,, extracorporeal membrane, oxygenation and in-hospital mortality rates were not significantly different between groups that received dexamethasone either within 24 hours of hypoxemia (early, dexamethasone, group) or 24 hours." provenance.
• SENTENCE label "(75 9% vs 40 0%, P-value=0 012) Further, early dexamethasone group showed a significantly shorter, total duration of oxygen supplementation, (10, 45 d, vs, 21, 61, d,, P-value=0, 003) and length of stay in the hospital (19 76 d, vs 27, 21, d,, P-value=0, 013), However,, extracorporeal membrane, oxygenation and in-hospital mortality rates were not significantly different between groups that received dexamethasone either within 24 hours of hypoxemia (early, dexamethasone, group) or 24 hours." provenance.
• SENTENCE label "(75 9% vs 40 0%, P-value=0 012) Further, early dexamethasone group showed a significantly shorter, total duration of oxygen supplementation, (10, 45 d, vs, 21, 61, d,, P-value=0, 003) and length of stay in the hospital (19 76 d, vs 27, 21, d,, P-value=0, 013), However,, extracorporeal membrane, oxygenation and in-hospital mortality rates were not significantly different between groups that received dexamethasone either within 24 hours of hypoxemia (early, dexamethasone, group) or 24 hours." provenance.
• SENTENCE label "(75 9% vs 40 0%, P-value=0 012) Further, early dexamethasone group showed a significantly shorter, total duration of oxygen supplementation, (10, 45 d, vs, 21, 61, d,, P-value=0, 003) and length of stay in the hospital (19 76 d, vs 27, 21, d,, P-value=0, 013), However,, extracorporeal membrane, oxygenation and in-hospital mortality rates were not significantly different between groups that received dexamethasone either within 24 hours of hypoxemia (early, dexamethasone, group) or 24 hours." provenance.
• SENTENCE label "(75 9% vs 40 0%, P-value=0 012) Further, early dexamethasone group showed a significantly shorter, total duration of oxygen supplementation, (10, 45 d, vs, 21, 61, d,, P-value=0, 003) and length of stay in the hospital (19 76 d, vs 27, 21, d,, P-value=0, 013), However,, extracorporeal membrane, oxygenation and in-hospital mortality rates were not significantly different between groups that received dexamethasone either within 24 hours of hypoxemia (early, dexamethasone, group) or 24 hours." provenance.
• SENTENCE label "(75 9% vs 40 0%, P-value=0 012) Further, early dexamethasone group showed a significantly shorter, total duration of oxygen supplementation, (10, 45 d, vs, 21, 61, d,, P-value=0, 003) and length of stay in the hospital (19 76 d, vs 27, 21, d,, P-value=0, 013), However,, extracorporeal membrane, oxygenation and in-hospital mortality rates were not significantly different between groups that received dexamethasone either within 24 hours of hypoxemia (early, dexamethasone, group) or 24 hours." provenance.
• SENTENCE label "(75 9% vs 40 0%, P-value=0 012) Further, early dexamethasone group showed a significantly shorter, total duration of oxygen supplementation, (10, 45 d, vs, 21, 61, d,, P-value=0, 003) and length of stay in the hospital (19 76 d, vs 27, 21, d,, P-value=0, 013), However,, extracorporeal membrane, oxygenation and in-hospital mortality rates were not significantly different between groups that received dexamethasone either within 24 hours of hypoxemia (early, dexamethasone, group) or 24 hours." provenance.
• SENTENCE label "(75 9% vs 40 0%, P-value=0 012) Further, early dexamethasone group showed a significantly shorter, total duration of oxygen supplementation, (10, 45 d, vs, 21, 61, d,, P-value=0, 003) and length of stay in the hospital (19 76 d, vs 27, 21, d,, P-value=0, 013), However,, extracorporeal membrane, oxygenation and in-hospital mortality rates were not significantly different between groups that received dexamethasone either within 24 hours of hypoxemia (early, dexamethasone, group) or 24 hours." provenance.
• SENTENCE label "(75 9% vs 40 0%, P-value=0 012) Further, early dexamethasone group showed a significantly shorter, total duration of oxygen supplementation, (10, 45 d, vs, 21, 61, d,, P-value=0, 003) and length of stay in the hospital (19 76 d, vs 27, 21, d,, P-value=0, 013), However,, extracorporeal membrane, oxygenation and in-hospital mortality rates were not significantly different between groups that received dexamethasone either within 24 hours of hypoxemia (early, dexamethasone, group) or 24 hours." provenance.
• SENTENCE label "(75 9% vs 40 0%, P-value=0 012) Further, early dexamethasone group showed a significantly shorter, total duration of oxygen supplementation, (10, 45 d, vs, 21, 61, d,, P-value=0, 003) and length of stay in the hospital (19 76 d, vs 27, 21, d,, P-value=0, 013), However,, extracorporeal membrane, oxygenation and in-hospital mortality rates were not significantly different between groups that received dexamethasone either within 24 hours of hypoxemia (early, dexamethasone, group) or 24 hours." provenance.
• SENTENCE label "(75 9% vs 40 0%, P-value=0 012) Further, early dexamethasone group showed a significantly shorter, total duration of oxygen supplementation, (10, 45 d, vs, 21, 61, d,, P-value=0, 003) and length of stay in the hospital (19 76 d, vs 27, 21, d,, P-value=0, 013), However,, extracorporeal membrane, oxygenation and in-hospital mortality rates were not significantly different between groups that received dexamethasone either within 24 hours of hypoxemia (early, dexamethasone, group) or 24 hours." provenance.
• SENTENCE label "(75 9% vs 40 0%, P-value=0 012) Further, early dexamethasone group showed a significantly shorter, total duration of oxygen supplementation, (10, 45 d, vs, 21, 61, d,, P-value=0, 003) and length of stay in the hospital (19 76 d, vs 27, 21, d,, P-value=0, 013), However,, extracorporeal membrane, oxygenation and in-hospital mortality rates were not significantly different between groups that received dexamethasone either within 24 hours of hypoxemia (early, dexamethasone, group) or 24 hours." provenance.
• SENTENCE label "(75 9% vs 40 0%, P-value=0 012) Further, early dexamethasone group showed a significantly shorter, total duration of oxygen supplementation, (10, 45 d, vs, 21, 61, d,, P-value=0, 003) and length of stay in the hospital (19 76 d, vs 27, 21, d,, P-value=0, 013), However,, extracorporeal membrane, oxygenation and in-hospital mortality rates were not significantly different between groups that received dexamethasone either within 24 hours of hypoxemia (early, dexamethasone, group) or 24 hours." provenance.
• SENTENCE label "(75 9% vs 40 0%, P-value=0 012) Further, early dexamethasone group showed a significantly shorter, total duration of oxygen supplementation, (10, 45 d, vs, 21, 61, d,, P-value=0, 003) and length of stay in the hospital (19 76 d, vs 27, 21, d,, P-value=0, 013), However,, extracorporeal membrane, oxygenation and in-hospital mortality rates were not significantly different between groups that received dexamethasone either within 24 hours of hypoxemia (early, dexamethasone, group) or 24 hours." provenance.
• SENTENCE label "(75 9% vs 40 0%, P-value=0 012) Further, early dexamethasone group showed a significantly shorter, total duration of oxygen supplementation, (10, 45 d, vs, 21, 61, d,, P-value=0, 003) and length of stay in the hospital (19 76 d, vs 27, 21, d,, P-value=0, 013), However,, extracorporeal membrane, oxygenation and in-hospital mortality rates were not significantly different between groups that received dexamethasone either within 24 hours of hypoxemia (early, dexamethasone, group) or 24 hours." provenance.
• SENTENCE label "(75 9% vs 40 0%, P-value=0 012) Further, early dexamethasone group showed a significantly shorter, total duration of oxygen supplementation, (10, 45 d, vs, 21, 61, d,, P-value=0, 003) and length of stay in the hospital (19 76 d, vs 27, 21, d,, P-value=0, 013), However,, extracorporeal membrane, oxygenation and in-hospital mortality rates were not significantly different between groups that received dexamethasone either within 24 hours of hypoxemia (early, dexamethasone, group) or 24 hours." provenance.
• SENTENCE label "(75 9% vs 40 0%, P-value=0 012) Further, early dexamethasone group showed a significantly shorter, total duration of oxygen supplementation, (10, 45 d, vs, 21, 61, d,, P-value=0, 003) and length of stay in the hospital (19 76 d, vs 27, 21, d,, P-value=0, 013), However,, extracorporeal membrane, oxygenation and in-hospital mortality rates were not significantly different between groups that received dexamethasone either within 24 hours of hypoxemia (early, dexamethasone, group) or 24 hours." provenance.
• SENTENCE label "(75 9% vs 40 0%, P-value=0 012) Further, early dexamethasone group showed a significantly shorter, total duration of oxygen supplementation, (10, 45 d, vs, 21, 61, d,, P-value=0, 003) and length of stay in the hospital (19 76 d, vs 27, 21, d,, P-value=0, 013), However,, extracorporeal membrane, oxygenation and in-hospital mortality rates were not significantly different between groups that received dexamethasone either within 24 hours of hypoxemia (early, dexamethasone, group) or 24 hours." provenance.
• SENTENCE label "(75 9% vs 40 0%, P-value=0 012) Further, early dexamethasone group showed a significantly shorter, total duration of oxygen supplementation, (10, 45 d, vs, 21, 61, d,, P-value=0, 003) and length of stay in the hospital (19 76 d, vs 27, 21, d,, P-value=0, 013), However,, extracorporeal membrane, oxygenation and in-hospital mortality rates were not significantly different between groups that received dexamethasone either within 24 hours of hypoxemia (early, dexamethasone, group) or 24 hours." provenance.
• SENTENCE label "(75 9% vs 40 0%, P-value=0 012) Further, early dexamethasone group showed a significantly shorter, total duration of oxygen supplementation, (10, 45 d, vs, 21, 61, d,, P-value=0, 003) and length of stay in the hospital (19 76 d, vs 27, 21, d,, P-value=0, 013), However,, extracorporeal membrane, oxygenation and in-hospital mortality rates were not significantly different between groups that received dexamethasone either within 24 hours of hypoxemia (early, dexamethasone, group) or 24 hours." provenance.
• SENTENCE label "(75 9% vs 40 0%, P-value=0 012) Further, early dexamethasone group showed a significantly shorter, total duration of oxygen supplementation, (10, 45 d, vs, 21, 61, d,, P-value=0, 003) and length of stay in the hospital (19 76 d, vs 27, 21, d,, P-value=0, 013), However,, extracorporeal membrane, oxygenation and in-hospital mortality rates were not significantly different between groups that received dexamethasone either within 24 hours of hypoxemia (early, dexamethasone, group) or 24 hours." provenance.
• SENTENCE label "(75 9% vs 40 0%, P-value=0 012) Further, early dexamethasone group showed a significantly shorter, total duration of oxygen supplementation, (10, 45 d, vs, 21, 61, d,, P-value=0, 003) and length of stay in the hospital (19 76 d, vs 27, 21, d,, P-value=0, 013), However,, extracorporeal membrane, oxygenation and in-hospital mortality rates were not significantly different between groups that received dexamethasone either within 24 hours of hypoxemia (early, dexamethasone, group) or 24 hours." provenance.
• SENTENCE label "(75 9% vs 40 0%, P-value=0 012) Further, early dexamethasone group showed a significantly shorter, total duration of oxygen supplementation, (10, 45 d, vs, 21, 61, d,, P-value=0, 003) and length of stay in the hospital (19 76 d, vs 27, 21, d,, P-value=0, 013), However,, extracorporeal membrane, oxygenation and in-hospital mortality rates were not significantly different between groups that received dexamethasone either within 24 hours of hypoxemia (early, dexamethasone, group) or 24 hours." provenance.
• SENTENCE label "(75 9% vs 40 0%, P-value=0 012) Further, early dexamethasone group showed a significantly shorter, total duration of oxygen supplementation, (10, 45 d, vs, 21, 61, d,, P-value=0, 003) and length of stay in the hospital (19 76 d, vs 27, 21, d,, P-value=0, 013), However,, extracorporeal membrane, oxygenation and in-hospital mortality rates were not significantly different between groups that received dexamethasone either within 24 hours of hypoxemia (early, dexamethasone, group) or 24 hours." provenance.